CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial Post author: Post published:April 25, 2024 Post category:News Feed Post comments:0 Comments Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. You Might Also Like Under the radar men’s health red flags may point to heart problems August 27, 2024 Scientists close in on TB blood test which could detect millions of silent spreaders March 22, 2024 New mathematical model sheds light on the absence of breastfeeding in male mammals June 30, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.